Work

Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma

Year: 2018

Type: article

Source: Melanoma Research

DOI: 10.1097/cmr.0000000000000509

Authors: Shalin Shah, Jason J. Luke, Heather A. Jacene, Tianqi Chen, Anita Giobbie-Hurder, Nageatte Ibrahim, Elizabeth L. Buchbinder, David F. McDermott, Keith T. Flaherty, Ryan J. Sullivan, Donald P. Lawrence, Patrick A. Ott, F. Stephen Hodi

Institutions: Medical University of South Carolina, University of Chicago, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Massachusetts General Hospital

Language: English

Topic: Ocular Oncology and Treatments

Subfield: Ophthalmology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2892989595

FWCI: 3.78

Cites: 36

Cited by: 37

Related to: 10